Ulcerative colitis: prescription and formulation support

A practical guide alongside your clinical care

Ulcerative colitis is a form of inflammatory bowel disease affecting the large bowel. Treatment and monitoring depend on the individual condition and clinical plan. NHS advice is to keep taking prescribed medicines even when symptoms are controlled, unless your clinical team changes the instructions. This guide does not recommend a treatment or assess a flare.

Source: NHS: ulcerative colitis ↗

Keep brands and pharmaceutical forms visible

A medicine may come as tablets, granule sachets or a rectal preparation. Record the exact brand, strength and form rather than only the ingredient. If the label includes modified-release or gastro-resistant wording, keep that in the enquiry. Similar strengths on two boxes do not establish that the products are interchangeable.

Check the whole prescribed plan

Some treatment plans include more than one preparation. Count the remaining supply of each item and say which one is causing difficulty. A tablet supply being ready does not automatically resolve a problem with another preparation, and an online availability result is not permission to omit part of the prescribed treatment.

Give a stock problem and a flare different routes

If bowel symptoms worsen, contact your GP or IBD team through its agreed advice route. A pharmacy enquiry may still be useful for identifying the current prescription, but it cannot decide whether a change is needed for a flare. Tell the clinical team about any supply interruption when discussing symptoms.

Coordinate hospital advice with the next repeat

After a review, make sure the team issuing the prescription has the current plan. If an older repeat remains on the system, ask how it will be corrected. Explain which prescription has actually been sent to the pharmacy, and avoid requesting a second copy without clarifying the status of the first.

Have these details ready for a pharmacy conversation

• Exact brand, strength and form of each prescribed item.
• Current prescription status and supply remaining for each preparation.
• Any recent changes from the IBD team.
• The clinical team's contact route for worsening symptoms.

You do not need to include your diagnosis, date of birth or NHS number in an initial general website enquiry. The pharmacy will explain any records or consent checks needed later.

Factual information about an existing medicine

If a medicine is already on your prescription, its guide explains product details and precautions.

• Mesalazine formulations information